{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:42:54Z","timestamp":1793400174665,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10067-018-4315-8","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T05:26:43Z","timestamp":1538458003000},"page":"657-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The efficacy and safety of total glucosides of peony in the treatment of primary Sj\u00f6gren\u2019s syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial"],"prefix":"10.1007","volume":"38","author":[{"given":"Xia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"issue":"2","key":"4315_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jbspin.2014.10.018","volume":"82","author":"P Youinou","year":"2015","unstructured":"Youinou P, Pers JO (2015) Primary Sjogren's syndrome at a glance today. Joint Bone Spine 82(2):75\u201376. \n                    https:\/\/doi.org\/10.1016\/j.jbspin.2014.10.018","journal-title":"Joint Bone Spine"},{"issue":"4","key":"4315_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jama.2010.1014","volume":"304","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals M, Tzioufas AG, Stone JH, Siso A, Bosch X (2010) Treatment of primary Sjogren syndrome: a systematic review. JAMA 304(4):452\u2013460. \n                    https:\/\/doi.org\/10.1001\/jama.2010.1014","journal-title":"JAMA"},{"issue":"6","key":"4315_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4315_CR4","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2353\/ajpath.2009.090319","volume":"175","author":"GE Katsifis","year":"2009","unstructured":"Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am J Pathol 175(3):1167\u20131177. \n                    https:\/\/doi.org\/10.2353\/ajpath.2009.090319","journal-title":"Am J Pathol"},{"key":"4315_CR5","doi-asserted-by":"publisher","unstructured":"De Paiva CS, Chotikavanich S, Pangelinan SB, Pitcher JD, 3rd, Fang B, Zheng X, Ma P, Farley WJ, Siemasko KF, Niederkorn JY, Stern ME, Li DQ, Pflugfelder SC (2009) IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2 (3):243\u2013253. doi:\n                    https:\/\/doi.org\/10.1038\/mi.2009.5","DOI":"10.1038\/mi.2009.5"},{"issue":"6","key":"4315_CR6","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","volume":"74","author":"X Lin","year":"2015","unstructured":"Lin X, Rui K, Deng J, Tian J, Wang X, Wang S, Ko KH, Jiao Z, Chan VS, Lau CS, Cao X, Lu L (2015) Th17 cells play a critical role in the development of experimental Sjogren's syndrome. Ann Rheum Dis 74(6):1302\u20131310. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-204584","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4315_CR7","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10792-014-9901-4","volume":"34","author":"H Deveci","year":"2014","unstructured":"Deveci H, Kobak S (2014) The efficacy of topical 0.05% cyclosporine A in patients with dry eye disease associated with Sjogren's syndrome. Int Ophthalmol 34(5):1043\u20131048. \n                    https:\/\/doi.org\/10.1007\/s10792-014-9901-4","journal-title":"Int Ophthalmol"},{"issue":"7","key":"4315_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000551","volume":"94","author":"T Lin","year":"2015","unstructured":"Lin T, Gong L (2015) Topical fluorometholone treatment for ocular dryness in patients with Sjogren syndrome: a randomized clinical trial in China. Medicine (Baltimore) 94(7):e551. \n                    https:\/\/doi.org\/10.1097\/md.0000000000000551","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"4315_CR9","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1002\/lary.25239","volume":"125","author":"K Tanner","year":"2015","unstructured":"Tanner K, Nissen SL, Merrill RM, Miner A, Channell RW, Miller KL, Elstad M, Kendall KA, Roy N (2015) Nebulized isotonic saline improves voice production in Sjogren's syndrome. Laryngoscope 125(10):2333\u20132340. \n                    https:\/\/doi.org\/10.1002\/lary.25239","journal-title":"Laryngoscope"},{"issue":"5","key":"4315_CR10","first-page":"555","volume":"14","author":"FN Skopouli","year":"1996","unstructured":"Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM (1996) Methotrexate in primary Sjogren's syndrome. Clin Exp Rheumatol 14(5):555\u2013558","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"4315_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"JE Gottenberg","year":"2014","unstructured":"Gottenberg JE, Ravaud P, Puechal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, Sene D, Zarnitsky C, Batouche D, Furlan V, Benessiano J, Perrodeau E, Seror R, Mariette X (2014) Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER randomized clinical trial. JAMA 312(3):249\u2013258. \n                    https:\/\/doi.org\/10.1001\/jama.2014.7682","journal-title":"JAMA"},{"issue":"4","key":"4315_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/M13-1085","volume":"160","author":"V Devauchelle-Pensec","year":"2014","unstructured":"Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puechal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Pers JO, Nowak E, Saraux A (2014) Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann Intern Med 160(4):233\u2013242. \n                    https:\/\/doi.org\/10.7326\/m13-1085","journal-title":"Ann Intern Med"},{"issue":"8","key":"4315_CR13","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/ard.2006.060905","volume":"66","author":"JM Woerkom van","year":"2007","unstructured":"van Woerkom JM, Kruize AA, Geenen R, van Roon EN, Goldschmeding R, Verstappen SM, van Roon JA, Bijlsma JW (2007) Safety and efficacy of leflunomide in primary Sjogren's syndrome: a phase II pilot study. Ann Rheum Dis 66(8):1026\u20131032. \n                    https:\/\/doi.org\/10.1136\/ard.2006.060905","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4315_CR14","first-page":"896","volume":"25","author":"EJ Price","year":"1998","unstructured":"Price EJ, Rigby SP, Clancy U, Venables PJ (1998) A double blind placebo controlled trial of azathioprine in the treatment of primary Sjogren's syndrome. J Rheumatol 25(5):896\u2013899","journal-title":"J Rheumatol"},{"issue":"6","key":"4315_CR15","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/ar2322","volume":"9","author":"P Willeke","year":"2007","unstructured":"Willeke P, Schluter B, Becker H, Schotte H, Domschke W, Gaubitz M (2007) Mycophenolate sodium treatment in patients with primary Sjogren syndrome: a pilot trial. Arthritis Res Ther 9(6):R115. \n                    https:\/\/doi.org\/10.1186\/ar2322","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"4315_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.autrev.2007.02.004","volume":"6","author":"F Atzeni","year":"2007","unstructured":"Atzeni F, Doria A, Turiel M, Sarzi-Puttini P (2007) What is the role of rituximab in the treatment of rheumatoid arthritis? Autoimmun Rev 6(8):553\u2013558. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2007.02.004","journal-title":"Autoimmun Rev"},{"issue":"7","key":"4315_CR17","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","volume":"73","author":"PM Meiners","year":"2014","unstructured":"Meiners PM, Vissink A, Kroese FG, Spijkervet FK, Smitt-Kamminga NS, Abdulahad WH, Bulthuis-Kuiper J, Brouwer E, Arends S, Bootsma H (2014) Abatacept treatment reduces disease activity in early primary Sjogren's syndrome (open-label proof of concept ASAP study). Ann Rheum Dis 73(7):1393\u20131396. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-204653","journal-title":"Ann Rheum Dis"},{"key":"4315_CR18","doi-asserted-by":"publisher","unstructured":"De Vita S, Quartuccio L, Seror R, Salvin S, Ravaud P, Fabris M, Nocturne G, Gandolfo S, Isola M, Mariette X (2015) Efficacy and safety of belimumab given for 12 months in primary Sjogren's syndrome: the BELISS open-label phase II study. Rheumatology (Oxford) 54 (12):2249\u20132256. doi:\n                    https:\/\/doi.org\/10.1093\/rheumatology\/kev257","DOI":"10.1093\/rheumatology\/kev257"},{"key":"4315_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00010","volume":"2","author":"DY He","year":"2011","unstructured":"He DY, Dai SM (2011) Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall., a traditional chinese herbal medicine. Front Pharmacol 2:10. \n                    https:\/\/doi.org\/10.3389\/fphar.2011.00010","journal-title":"Front Pharmacol"},{"issue":"3","key":"4315_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.intimp.2012.07.012","volume":"14","author":"Z Zhou","year":"2012","unstructured":"Zhou Z, Lin J, Huo R, Huang W, Zhang J, Wang L, Sun Y, Shen B, Li N (2012) Total glucosides of paeony attenuated functional maturation of dendritic cells via blocking TLR4\/5 signaling in vivo. Int Immunopharmacol 14(3):275\u2013282. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2012.07.012","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"4315_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cellimm.2012.12.005","volume":"280","author":"J Lin","year":"2012","unstructured":"Lin J, Xiao L, Ouyang G, Shen Y, Huo R, Zhou Z, Sun Y, Zhu X, Zhang J, Shen B, Li N (2012) Total glucosides of paeony inhibits Th1\/Th17 cells via decreasing dendritic cells activation in rheumatoid arthritis. Cell Immunol 280(2):156\u2013163. \n                    https:\/\/doi.org\/10.1016\/j.cellimm.2012.12.005","journal-title":"Cell Immunol"},{"key":"4315_CR22","doi-asserted-by":"publisher","unstructured":"Li CL, He J, Li ZG, Zheng LW, H. H (2013) Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: an animal study. J Craniomaxillofac Surg 41 (7):610\u2013615. doi:\n                    https:\/\/doi.org\/10.1016\/j.jcms.2012.11.042","DOI":"10.1016\/j.jcms.2012.11.042"},{"issue":"1","key":"4315_CR23","first-page":"173","volume":"19","author":"GL Wu","year":"2015","unstructured":"Wu GL, Pu XH, Yu GY, Li TY (2015) Effects of total glucosides of peony on AQP-5 and its mRNA expression in submandibular glands of NOD mice with Sjogren's syndrome. Eur Rev Med Pharmacol Sci 19(1):173\u2013178","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4315_CR24","first-page":"370","volume":"27","author":"XM Li","year":"2006","unstructured":"Li XM, Li XP, Wang GS, Qian L, Wang W (2006) Effectiveness and safety of total glucosides of peony in the treatment of patients with Sj\u00f6gren syndrome. Anhui Medical Journal 27:370\u2013371","journal-title":"Anhui Medical Journal"},{"issue":"7","key":"4315_CR25","first-page":"596","volume":"27","author":"HF Zhang","year":"2007","unstructured":"Zhang HF, Hou P, Xiao WG (2007) Clinical observation on effect of total glucosides of paeony in treating patients with non-systemic involved Sjogren syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 27(7):596\u2013598","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"4315_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.intimp.2016.08.006","volume":"39","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Jin L, Kong F, Zhang H, Fang X, Chen Z, Wang G, Li X, Li X (2016) Clinical and immunological consequences of total glucosides of paeony treatment in Sjogren's syndrome: a randomized controlled pilot trial. Int Immunopharmacol 39:314\u2013319. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2016.08.006","journal-title":"Int Immunopharmacol"},{"issue":"4 Suppl 98","key":"4315_CR27","first-page":"58","volume":"34","author":"F Barone","year":"2016","unstructured":"Barone F, Colafrancesco S (2016) Sjogren's syndrome: from pathogenesis to novel therapeutic targets. Clin Exp Rheumatol 34(4 Suppl 98):58\u201362","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"4315_CR28","first-page":"522","volume":"35","author":"J Lu","year":"2006","unstructured":"Lu J, Yang PT, Shen H, Xiao WG, Zhao LJ (2006) Clinical application of total glucosides of paeony in Sjogren syndrome. J Chin Med Univ 35(5):522\u2013524","journal-title":"J Chin Med Univ"}],"updated-by":[{"DOI":"10.1007\/s10067-018-4378-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T00:00:00Z","timestamp":1543795200000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4315-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4315-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4315-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T16:18:11Z","timestamp":1572020291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4315-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4315"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4315-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10067-018-4378-6","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"29 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors regret that the Fig.\u00a01 in the original version of this article contained an error. In the left column, 211 cases in the TGP group should be followed up for 8\u00a0weeks before 12\u00a0weeks. The correct figure presented in this article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}